{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:42:36Z","timestamp":1777452156701,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The hip fracture is one major clinical challenge associated with osteoporosis, resulting in heavy socioeconomic burdens and high mortality. Systemic therapies of anti-osteoporosis drugs are expensive, time-consuming and also evoke substantial side effects, which fails to provide early protection from fractures. Accumulating evidence demonstrates the high bioavailability and therapeutic efficacy of local drug delivery in accelerating facture healing and bone defect repair. This study aims at investigating the effects of local delivery of BMP2 and zoledronate (two promising anabolic\/anti-catobolic reagents) encapsulated by fibrin sealants into femoral necks on regulating bone quality and remodeling in osteoporotic rabbits subjected to combined ovariectomy and glucocorticoid injection. We show that 6-week BMP2 delivery exhibited more prominent effect on mitigating trabecular bone microarchitecture deterioration and mechanical strength reduction of femoral necks than local zoledronate treatment. BMP2 plus zoledronate showed more significant improvement of bone microstructure, mechanical strength and bone formation rate at 12 weeks post injection than single BMP2 or zoledronate delivery via \u03bcCT, biomechanical, histomorphometric and serum biochemical analyses. This study enriches our knowledge for understanding the availability of local drug delivery for improving bone quantity and quality, which may lead to earlier, safer and more efficient protection from osteoporosis-induced fractures in clinics.<\/jats:p>","DOI":"10.1038\/srep28537","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T06:10:09Z","timestamp":1466662209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of local delivery of BMP2, zoledronate and their combination on bone microarchitecture, biomechanics and bone turnover in osteoporotic rabbits"],"prefix":"10.1038","volume":"6","author":[{"given":"Da","family":"Jing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuguang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"BFsrep28537_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster, J. Y. & Burlet, N. Osteoporosis: a still increasing prevalence. Bone 38, S4\u20139 (2006).","journal-title":"Bone"},{"key":"BFsrep28537_CR2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1503\/cmaj.092220","volume":"182","author":"N Simunovic","year":"2010","unstructured":"Simunovic, N. et al. Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ 182, 1609\u20131616 (2010).","journal-title":"CMAJ"},{"key":"BFsrep28537_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","volume":"7","author":"B Gullberg","year":"1997","unstructured":"Gullberg, B., Johnell, O. & Kanis, J. A. World-wide projections for hip fracture. Osteoporos Int 7, 407\u2013413 (1997).","journal-title":"Osteoporos Int"},{"key":"BFsrep28537_CR4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell, O. & Kanis, J. A. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15, 897\u2013902 (2004).","journal-title":"Osteoporos Int"},{"key":"BFsrep28537_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","volume":"6","author":"N Harvey","year":"2010","unstructured":"Harvey, N., Dennison, E. & Cooper, C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6, 99\u2013105 (2010).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep28537_CR6","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1359\/jbmr.1998.13.9.1483","volume":"13","author":"RD Welch","year":"1998","unstructured":"Welch, R. D. et al. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13, 1483\u20131490 (1998).","journal-title":"J Bone Miner Res"},{"key":"BFsrep28537_CR7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2106\/JBJS.E.00381","volume":"88","author":"AL Jones","year":"2006","unstructured":"Jones, A. L. et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88, 1431\u20131441 (2006).","journal-title":"J Bone Joint Surg Am"},{"key":"BFsrep28537_CR8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jcb.10231","volume":"86","author":"G Turgeman","year":"2002","unstructured":"Turgeman, G. et al. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86, 461\u2013474 (2002).","journal-title":"J Cell Biochem"},{"key":"BFsrep28537_CR9","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/jcb.25164","volume":"116","author":"MB Rogers","year":"2015","unstructured":"Rogers, M. B., Shah, T. A. & Shaikh, N. N. Turning Bone Morphogenetic Protein 2 (BMP2) on and off in Mesenchymal Cells. J Cell Biochem 116, 2127\u20132138 (2015).","journal-title":"J Cell Biochem"},{"key":"BFsrep28537_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.carbpol.2013.12.023","volume":"103","author":"EC Kim","year":"2014","unstructured":"Kim, E. C., Kim, T. H., Jung, J. H., Hong, S. O. & Lee, D. W. Enhanced osteogenic differentiation of MC3T3-E1 on rhBMP-2-immobilized titanium via click reaction. Carbohydr Polym 103, 170\u2013178 (2014).","journal-title":"Carbohydr Polym"},{"key":"BFsrep28537_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2443.2008.01258.x","volume":"14","author":"MM Sato","year":"2009","unstructured":"Sato, M. M., Nakashima, A., Nashimoto, M., Yawaka, Y. & Tamura, M. Bone morphogenetic protein-2 enhances Wnt\/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells 14, 141\u2013153 (2009).","journal-title":"Genes Cells"},{"key":"BFsrep28537_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.09.023","volume":"58","author":"EF Eriksen","year":"2014","unstructured":"Eriksen, E. F., Diez-Perez, A. & Boonen, S. Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 58, 126\u2013135 (2014).","journal-title":"Bone"},{"key":"BFsrep28537_CR13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black, D. M. et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356, 1809\u20131822 (2007).","journal-title":"N Engl J Med"},{"key":"BFsrep28537_CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2005.09.198","volume":"338","author":"A Schindeler","year":"2005","unstructured":"Schindeler, A. & Little, D. G. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Biochem Biophys Res Commun 338, 710\u2013716 (2005).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep28537_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.actbio.2014.09.006","volume":"11","author":"L Kyllonen","year":"2015","unstructured":"Kyllonen, L., D\u2019Este, M., Alini, M. & Eglin, D. Local drug delivery for enhancing fracture healing in osteoporotic bone. Acta Biomater 11, 412\u2013434 (2015).","journal-title":"Acta Biomater"},{"key":"BFsrep28537_CR16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","volume":"288","author":"HD Nelson","year":"2002","unstructured":"Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M. & Allan, J. D. Postmenopausal hormone replacement therapy: scientific review. JAMA 288, 872\u2013881 (2002).","journal-title":"JAMA"},{"key":"BFsrep28537_CR17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/heartjnl-2011-301345","volume":"98","author":"K Li","year":"2012","unstructured":"Li, K., Kaaks, R., Linseisen, J. & Rohrmann, S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98, 920\u2013925 (2012).","journal-title":"Heart"},{"key":"BFsrep28537_CR18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1365-2036.2000.00864.x","volume":"14","author":"JK Marshall","year":"2000","unstructured":"Marshall, J. K., Rainsford, K. D., James, C. & Hunt, R. H. A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract. Aliment Pharmacol Ther 14, 1451\u20131457 (2000).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep28537_CR19","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s11999-010-1321-9","volume":"468","author":"M Li","year":"2010","unstructured":"Li, M., Liu, X. & Ge, B. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res 468, 1978\u20131985 (2010).","journal-title":"Clin Orthop Relat Res"},{"key":"BFsrep28537_CR20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.spinee.2013.06.010","volume":"13","author":"SB Park","year":"2013","unstructured":"Park, S. B., Park, S. H., Kim, N. H. & Chung, C. K. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model. Spine J 13, 1273\u20131280 (2013).","journal-title":"Spine J"},{"key":"BFsrep28537_CR21","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s11999-009-1004-6","volume":"467","author":"S Sarban","year":"2009","unstructured":"Sarban, S., Senkoylu, A., Isikan, U. E., Korkusuz, P. & Korkusuz, F. Can rhBMP-2 containing collagen sponges enhance bone repair in ovariectomized rats? a preliminary study. Clin Orthop Relat Res 467, 3113\u20133120 (2009).","journal-title":"Clin Orthop Relat Res"},{"key":"BFsrep28537_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00776-010-0019-x","volume":"16","author":"ZX Wu","year":"2011","unstructured":"Wu, Z. X. et al. Sustained-release rhBMP-2 increased bone mass and bone strength in an ovine model of postmenopausal osteoporosis. J Orthop Sci 16, 99\u2013104 (2011).","journal-title":"J Orthop Sci"},{"key":"BFsrep28537_CR23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jor.22387","volume":"31","author":"MR Zarrinkalam","year":"2013","unstructured":"Zarrinkalam, M. R., Schultz, C. G., Ardern, D. W., Vernon-Roberts, B. & Moore, R. J. Recombinant human bone morphogenetic protein-type 2 (rhBMP-2) enhances local bone formation in the lumbar spine of osteoporotic sheep. J Orthop Res 31, 1390\u20131397 (2013).","journal-title":"J Orthop Res"},{"key":"BFsrep28537_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bone.2004.10.004","volume":"36","author":"B Peter","year":"2005","unstructured":"Peter, B. et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 36, 52\u201360 (2005).","journal-title":"Bone"},{"key":"BFsrep28537_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0022034512472335","volume":"92","author":"J Abtahi","year":"2013","unstructured":"Abtahi, J., Agholme, F., Sandberg, O. & Aspenberg, P. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw. J Dent Res 92, 279\u2013283 (2013).","journal-title":"J Dent Res"},{"key":"BFsrep28537_CR26","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.actbio.2014.01.016","volume":"10","author":"CM Murphy","year":"2014","unstructured":"Murphy, C. M. et al. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acta Biomater 10, 2250\u20132258 (2014).","journal-title":"Acta Biomater"},{"key":"BFsrep28537_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.22203\/eCM.v025a14","volume":"25","author":"NY Yu","year":"2013","unstructured":"Yu, N. Y. et al. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation. Eur Cell Mater 25, 190\u2013203 (2013).","journal-title":"Eur Cell Mater"},{"key":"BFsrep28537_CR28","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843, 1\u2013129 (1994)."},{"key":"BFsrep28537_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bone.2008.10.054","volume":"44","author":"Y Gao","year":"2009","unstructured":"Gao, Y. et al. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone 44, 225\u2013232 (2009).","journal-title":"Bone"},{"key":"BFsrep28537_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbm.a.30456","volume":"76","author":"B Peter","year":"2006","unstructured":"Peter, B. et al. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. J Biomed Mater Res A 76, 133\u2013143 (2006).","journal-title":"J Biomed Mater Res A"},{"key":"BFsrep28537_CR31","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0002-9610(01)00770-X","volume":"182","author":"MR Jackson","year":"2001","unstructured":"Jackson, M. R. Fibrin sealants in surgical practice: An overview. Am J Surg 182, 1S\u20137S (2001).","journal-title":"Am J Surg"},{"key":"BFsrep28537_CR32","first-page":"108","volume":"31","author":"PD Mintz","year":"2001","unstructured":"Mintz, P. D. et al. Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive Center. Ann Clin Lab Sci 31, 108\u2013118 (2001).","journal-title":"Ann Clin Lab Sci"},{"key":"BFsrep28537_CR33","unstructured":"Alston, S. M. Autologous fibrinogen purification and concentration for use in fibrin sealant. (Dissertation) Brigham Young University (2005)."},{"key":"BFsrep28537_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.06.025","volume":"148","author":"PP Spicer","year":"2010","unstructured":"Spicer, P. P. & Mikos, A. G. Fibrin glue as a drug delivery system. J Control Release 148, 49\u201355 (2010).","journal-title":"J Control Release"},{"key":"BFsrep28537_CR35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-0037-1613389","volume":"89","author":"C Wong","year":"2003","unstructured":"Wong, C., Inman, E., Spaethe, R. & Helgerson, S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 89, 573\u2013582 (2003).","journal-title":"Thromb Haemost"},{"key":"BFsrep28537_CR36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0142-9612(99)00280-X","volume":"21","author":"C Perka","year":"2000","unstructured":"Perka, C. et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21, 1145\u20131153 (2000).","journal-title":"Biomaterials"},{"key":"BFsrep28537_CR37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00006534-200003000-00019","volume":"105","author":"N Isogai","year":"2000","unstructured":"Isogai, N. et al. Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast Reconstr Surg 105, 953\u2013963 (2000).","journal-title":"Plast Reconstr Surg"},{"key":"BFsrep28537_CR38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bone.2005.05.002","volume":"37","author":"S Schorlemmer","year":"2005","unstructured":"Schorlemmer, S., Ignatius, A., Claes, L. & Augat, P. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep. Bone 37, 491\u2013496 (2005).","journal-title":"Bone"},{"key":"BFsrep28537_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(01)00498-9","volume":"78","author":"JY Lee","year":"2002","unstructured":"Lee, J. Y. et al. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 78, 187\u2013197 (2002).","journal-title":"J Control Release"},{"key":"BFsrep28537_CR40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SAP.0b013e3181a73045","volume":"64","author":"HI Canter","year":"2010","unstructured":"Canter, H. I. et al. Effect of use of slow release of bone morphogenetic protein-2 and transforming growth factor-Beta-2 in a chitosan gel matrix on cranial bone graft survival in experimental cranial critical size defect model. Ann Plast Surg 64, 342\u2013350 (2010).","journal-title":"Ann Plast Surg"},{"key":"BFsrep28537_CR41","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2012-4039","volume":"98","author":"A Catalano","year":"2013","unstructured":"Catalano, A. et al. Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 98, 1911\u20131915 (2013).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep28537_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1359\/jbmr.1997.12.1.111","volume":"12","author":"S Majumdar","year":"1997","unstructured":"Majumdar, S. et al. Correlation of trabecular bone structure with age, bone mineral density and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res 12, 111\u2013118 (1997).","journal-title":"J Bone Miner Res"},{"key":"BFsrep28537_CR43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1359\/jbmr.2000.15.1.13","volume":"15","author":"E Legrand","year":"2000","unstructured":"Legrand, E. et al. Trabecular bone microarchitecture, bone mineral density and vertebral fractures in male osteoporosis. J Bone Miner Res 15, 13\u201319 (2000).","journal-title":"J Bone Miner Res"},{"key":"BFsrep28537_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/iep.12038","volume":"94","author":"P Govindarajan","year":"2013","unstructured":"Govindarajan, P. et al. Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone. Int J Exp Pathol 94, 387\u2013398 (2013).","journal-title":"Int J Exp Pathol"},{"key":"BFsrep28537_CR45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/17453674.2010.483986","volume":"81","author":"L Baofeng","year":"2010","unstructured":"Baofeng, L. et al. Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid. Acta Orthop 81, 396\u2013401 (2010).","journal-title":"Acta Orthop"},{"key":"BFsrep28537_CR46","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s00198-002-1345-4","volume":"14","author":"P Ammann","year":"2003","unstructured":"Ammann, P. & Rizzoli, R. Bone strength and its determinants. Osteoporos Int 14 Suppl 3, S13\u201318 (2003).","journal-title":"Osteoporos Int"},{"key":"BFsrep28537_CR47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1302\/0301-620X.87B4.15498","volume":"87","author":"AJ Shimmin","year":"2005","unstructured":"Shimmin, A. J. & Back, D. Femoral neck fractures following Birmingham hip resurfacing: a national review of 50 cases. J Bone Joint Surg Br 87, 463\u2013464 (2005).","journal-title":"J Bone Joint Surg Br"},{"key":"BFsrep28537_CR48","doi-asserted-by":"crossref","unstructured":"Leichter, I. et al. The relationship between bone density, mineral content and mechanical strength in the femoral neck. Clin Orthop Relat Res, 272\u2013281 (1982).","DOI":"10.1097\/00003086-198203000-00041"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep28537","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:58:00Z","timestamp":1672851480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep28537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,13]]}},"alternative-id":["BFsrep28537"],"URL":"https:\/\/doi.org\/10.1038\/srep28537","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28537"}}